期刊文献+

非体外循环下冠状动脉旁路移植术患者不同抗血小板方案对乳内动脉桥血管通畅率影响的临床研究 被引量:4

Clinical study on the effect of different antiplatelet regimens on patency rate of internal mammary artery bridge after off-pump coronary artery bypass grafting
下载PDF
导出
摘要 目的:对比研究非体外循环下冠状动脉旁路移植术(OPCABG)后,分别运用单抗(阿司匹林)与双抗(阿司匹林+氯吡格雷)抗血小板治疗后,对远期乳内动脉桥血管通畅率的影响。方法:回顾性分析2005年01月至2005年12月,在安贞医院心脏外科固定手术组行OPCABG并顺利出院的230例患者的临床资料,并对其进行随访。结果:随访时间为150个月,随访期内心脏相关死亡54例(16.4%)。两组前降支通畅率分别为65.8%、66.4%(P>0.05)。结论:对于OPCABG的患者,无论给与双抗或单抗,其远期效果并无明显差异,但短期内前降支通畅率变化趋势,双抗组优于单抗组。 Objective: To compare the effects of antiplatelet therapy with monoclonal antibody(aspirin) and double antibody(aspirin + clopidogrel) on long-term patency of intramammary artery bridge after off-pump coronary artery bypass grafting(OPCABG). Methods: From January 2005 to December 2005, the clinical data of 230 patients who underwent OPCABG and successfully discharged from the same operation group in Anzhen Hospital were analyzed and followed up. Results: The follow-up period was 150 months. 54 cases(16.4%) died of heart-related diseases during the follow-up period. The patency rate of anterior descending branch in the two groups was 65.8% and 66.4%(P>0.05). Conclusions:For patients with OPCABG, there was no significant difference in the long-term effect between the two groups, but in the short term, the patency rate of anterior descending artery in the two groups was better than that in the monoclonal antibody group.
作者 杨昭 李温斌 白瑞凯 宋士秋 周子凡 顾成雄 黄方炯 张健群 伯平 YANG Zhao;LI Wenbin;BAI Ruikai;SONG Shiqiu;ZHOU Zifan;GU Chengxiong;HUANG Fangjiong;ZHANG Jianqun;BO Ping(Department of Cardiac Surgery,Beijing Anzhen Hospital,Capital Medical University,Beijing Institute of Heart,Lung and Blood Vessel Diseases,Beijing 100029,China)
出处 《心肺血管病杂志》 2020年第3期276-279,共4页 Journal of Cardiovascular and Pulmonary Diseases
关键词 冠心病 冠状动脉旁路移植术 抗凝治疗 桥血管通畅率 Coronary heart disease Coronary artery bypass grafting Anticoagulant therapy Bridging vessel patency rate
  • 相关文献

参考文献3

二级参考文献23

  • 1Lin L,Jian C,Li F,et al. Prevalence and risk factors for aspi rin resistance in elderly patients with type 2 diabetes. Interna tional Journal of Gerontology, 2011,5 : 112-116.
  • 2Richard FG, Munir P. Aspirin resistance : Effect of clinical, bi ochemical and genetic factors. Pharmacology Therapeutics 2011,130:213-225.
  • 3Hankey GJ, Eikelboom JW. Aspirin resistance. Lancet, 2006, 9510606 616.
  • 4Whitea RE,Gerrityb R,Barmana SA,ct al. Estrogen and oxi- dative stress: A novel mechanism that may increase the risk for cardiovascular disease in women. Steroids, 2010,75: 788- 793.
  • 5Opotowsky AR, McWilliams JM, Cannon CP, et al. Gender differences in aspirin use among adults with coronary heart disease in the United States. J Gen Intern Med,2007,22:55-61.
  • 6Hovens MMC, Snoep JD, Groeneveld Y, et al. High levels of low density lipoprotein cholesterol and triglycerides and sub- optimal glycemic control predict exc vivo aspirin responsive ness in patients with type 2 diabetes. J Thromb Haemost, 2007,5 : 1562-1564.
  • 7Karepov V,Tolpina G,Kuliczkowski W,et al. Plasma triglyc- erides as predictors of platelet responsiveness to aspirin in pa tients aher first ischemic stroke. Cerebrovasc Dis, 2008,26: 272 276.
  • 8Tirnaksiz E, Pamukcu B, Ofiaz H, et al. Effect of high dose statin therapy on platelet function statins reduce aspirin-re- sistant platelet aggregation in patients with coronary heart disease. J Thromb Thrombolysis,2009,27:24-28.
  • 9Valles J, Santos MT, Fuset MP, et al. Partial inhibition of platelet thromboxane A2 Synthesis by aspirin is associated with myonecrosis in patients with ST-segment elevation myo- cardial infarction. Am J Cardiol, 2007,99 : 19 25.
  • 10Eikelboom JW, Hankey GJ, Thorn J, et al. Incomplete inhibi- tion of thromboxane biosynthesis by acetylsalicylie acid. De- terminants and effect on cardiovascular risks. Circulation, 2008,18 : 1705-1712.

共引文献26

同被引文献42

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部